Volume 91, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Antivenoms manufactured by bioCSL Limited (Australia) and Instituto Clodomiro Picado (Costa Rica) against the venom of the taipan snakes () from Australia and Papua New Guinea (PNG), respectively, were compared using antivenomics, an analytical approach that combines proteomics with immunoaffinity chromatography. Both antivenoms recognized all venom proteins present in venom from PNG , although a pattern of partial recognition was observed for some components. In the case of the Australian venom, both antivenoms immunorecognized the majority of the components, but the CSL antivenom showed a stronger pattern of immunoreactivity, which was revealed by the percentage of retained proteins in the immunoaffinity column. Antivenoms interacted with taipoxin in surface plasmon resonance. These observations on antivenomics agree with previous neutralization studies.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Currie BJ, Sutherland SK, Hudson BJ, Smith AM, , 1991. An epidemiological study of snakebite envenomation in Papua New Guinea. Med J Aust 154: 266268. [Google Scholar]
  2. Lalloo DG, Trevett AJ, Korinhona A, Nwokolo N, Laurenson IF, Paul M, Black J, Naraqi S, Mavo B, Saweri A, Hutton RA, Theakston RDG, Warrell DA, , 1995. Snake bites by the Papuan taipan (Oxyuranus scutellatus canni): paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom. Am J Trop Med Hyg 52: 525531. [Google Scholar]
  3. Williams D, Williams DJ, Jensen SD, Nimorakiotakis B, Winkel KD, , 2005. Snakebite in Papua New Guinea. , eds. Venomous Bites and Stings in Papua New Guinea: A Treatment Guide for Health Workers and Doctors. Melbourne, Australia: University of Melbourne, 532. [Google Scholar]
  4. Lalloo DG, Trevett AJ, Owens D, Minei J, Naraqi S, Saweri A, Hutton RA, Theakston RDG, Warrell DA, , 1995. Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni). Blood Coagul Fibrinolysis 6: 6572.[Crossref] [Google Scholar]
  5. Lalloo DG, Trevett AJ, Nwokolo N, Laurenson IF, Naraqi S, Kevau I, Kemp MW, James R, Hooper L, Theakston RDG, Warrell DA, , 1997. Electrocardiographic abnormalities in patients bitten by taipans (Oxyuranus scutellatus canni) and other elapid snakes in Papua New Guinea. Trans R Soc Trop Med Hyg 91: 5356.[Crossref] [Google Scholar]
  6. Trevett AJ, Lalloo DG, Nwokolo NC, Naraqi S, Kevau IH, Theakston RDG, Warrell DA, , 1995. Electrophysiological findings in patients envenomed following the bite of a Papuan taipan (Oxyuranus scutellatus canni). Trans R Soc Trop Med Hyg 89: 415417.[Crossref] [Google Scholar]
  7. O'Leary MA, Isbister GK, , 2009. Commercial monovalent antivenoms in Australia are polyvalent. Toxicon 54: 192195.[Crossref] [Google Scholar]
  8. Vargas M, Segura A, Herrera M, Villalta M, Estrada R, Cerdas M, Paiva O, Matainaho T, Jensen SD, Winkel KD, León G, Gutiérrez JM, Williams DJ, , 2011. Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea. PLoS Negl Trop Dis 5: e1144.[Crossref] [Google Scholar]
  9. Lomonte B, Escolano J, Fernández J, Sanz L, Angulo Y, Gutiérrez JM, Calvete JJ, , 2008. Snake venomics and antivenomics of the arboreal neotropical pitvipers Bothriechis lateralis and Bothriechis schlegelii . J Proteome Res 7: 24452457.[Crossref] [Google Scholar]
  10. Gutiérrez JM, Lomonte B, León G, Alape-Girón A, Flores-Díaz M, Sanz L, Angulo Y, Calvete JJ, , 2009. Snake venomics and antivenomics: proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming. J Proteomics 72: 165182.[Crossref] [Google Scholar]
  11. Calvete JJ, , 2011. Proteomic tools against the neglected pathology of snake bite envenoming. Expert Rev Proteomics 8: 739758.[Crossref] [Google Scholar]
  12. Pla D, Gutiérrez JM, Calvete JJ, , 2012. Second generation snake antivenomics: comparing immunoaffinity and immunodepletion protocols. Toxicon 60: 688699.[Crossref] [Google Scholar]
  13. Williams DJ, Gutiérrez JM, Calvete JJ, Wüster W, Ratanabanangkoon K, Paiva O, Brown NI, Casewell NR, Harrison RA, Rowley PD, O'Shea M, Jensen SD, Winkel KD, Warrell DA, , 2011. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa. J Proteomics 74: 17351767.[Crossref] [Google Scholar]
  14. Herrera M, Fernández J, Vargas M, Villalta M, Segura Á, León G, Angulo Y, Paiva O, Matainaho T, Jensen SD, Winkel KD, Calvete JJ, Williams DJ, Gutiérrez JM, , 2012. Comparative proteomic analysis of the venom of the taipan snake, Oxyuranus scutellatus, from Papua New Guinea and Australia: role of neurotoxic and procoagulant effects in venom toxicity. J Proteomics 75: 21282140.[Crossref] [Google Scholar]
  15. Fohlman J, Eaker D, Karlsson E, Thesleff S, , 1976. Taipoxin, an extremely potent presynaptic neurotoxin from the venom of the Australian snake taipan (Oxyuranus s. scutellatus). Isolation, characterization, quaternary structure and pharmacological properties. Eur J Biochem 68: 457469.[Crossref] [Google Scholar]
  16. Lambeau G, Barhanin J, Schweitz H, Qar J, Lazdunski M, , 1989. Identification and properties of very high affinity brain membrane-binding sites for a neurotoxic phospholipase from the taipan venom. J Biol Chem 264: 1150311510. [Google Scholar]
  17. Lambeau G, Cupillard L, Lazdunski M, Kini RM, , 1997. Membrane receptors for venom phospholipases A2 . , ed. Venom Phospholipase A2 Enzymes. Structure, Function and Mechanism. Chichester, United Kingdom: Wiley, 389412. [Google Scholar]
  18. Speiger H, Govers-Riemslag JWP, Swaal RFA, Rosing J, , 1986. Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (taipan snake). J Biol Chem 261: 1325813267. [Google Scholar]
  19. Calvete JJ, Cid P, Sanz L, Segura A, Villalta M, Herrera M, León G, Harrison R, Durfa N, Nasidi A, Theakston RDG, Warrell DA, Gutiérrez JM, , 2010. Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa. Am J Trop Med Hyg 82: 11941201.[Crossref] [Google Scholar]
  20. Kuruppu S, Reeve S, Banerjee Y, Kini RM, Smith I, Hodgson WC, , 2005. Isolation and pharmacological characterization of cannitoxin, a presynaptic neurotoxin from the venom of the Papuan taipan (Oxyuranus scutellatus canni). J Pharmacol Exp Ther 315: 11961202.[Crossref] [Google Scholar]
  21. Possani LD, Martin BM, Yatani A, Mochca-Morales J, Zamudio FZ, Gurrola GB, Brown AM, , 1992. Isolation and physiological characterization of taicatoxin, a complex toxin with specific effects on calcium channels. Toxicon 30: 13431364.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 29 May 2014
  • Accepted : 23 Jul 2014
  • Published online : 05 Nov 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error